Literature DB >> 23732398

Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood.

Ryoko Hamatani1, Miki Otsu, Hiroko Chikamoto, Yuko Akioka, Motoshi Hattori.   

Abstract

BACKGROUND: Hyperhomocysteinemia (hyper-Hcy) is an important and reversible cardiovascular disease risk factor. We examined the prevalence of hyper-Hcy, plasma folate levels, and dietary folate intake in adolescents and young adults who had undergone kidney transplantation during childhood to assess the necessity for managing dietary folate.
METHODS: This cross-sectional study was performed in 89 kidney transplant recipients (age at kidney transplantation: 12.6 ± 4.1 years; age during study: 21.2 ± 5.5 years). Hyper-Hcy and plasma folate deficiency were defined as plasma homocysteine (Hcy) >15 nmol/ml and plasma folate <3.0 ng/ml, respectively.
RESULTS: Of the patients, 60 (67.4 %) had hyper-Hcy and 14 (15.7 %) had plasma folate deficiency. Plasma homocysteine levels correlated negatively with estimated glomerular filtration rate (eGFR; r = -0.565, p < 0.01) and plasma folate levels (r = -0.434, p < 0.01). For determinants of plasma homocysteine levels, a priori selected variables included kind of calcineurin inhibitor, age at kidney transplantation, pretransplant duration of dialysis, time since transplantation, age at examination, eGFR, and plasma folate. Stepwise multiple linear regression analysis revealed eGFR and plasma folate levels as significant independent variables influencing plasma homocysteine levels. Dietary folate intake in 11 of 16 patients (66.8 %) with eGFR ≥ 60 ml/min/1.73 m(2) was below the recommended dietary allowance for Japanese.
CONCLUSIONS: The prevalence of hyper-Hcy and plasma folate deficiency, as well as the low dietary folate intake, suggest that dietary management of folate is necessary for adolescents and young adults who have undergone kidney transplantation during childhood.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732398     DOI: 10.1007/s10157-013-0819-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  22 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.

Authors:  Lutz Liefeldt; Klemens Budde
Journal:  Transpl Int       Date:  2010-09-07       Impact factor: 3.782

3.  Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins.

Authors:  Vandana Menon; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Jacob Selhub; Andrew S Levey; Mark J Sarnak
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

4.  Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.

Authors:  Xianhui Qin; Yong Huo; Craig B Langman; Fanfan Hou; Yundai Chen; Debora Matossian; Xiping Xu; Xiaobin Wang
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-18       Impact factor: 8.237

5.  Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.

Authors:  Wolfgang C Winkelmayer; Reinhard Kramar; Gary C Curhan; Anil Chandraker; Georg Endler; Manuela Födinger; Walter H Hörl; Gere Sunder-Plassmann
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

6.  Homocysteine level and coronary artery disease.

Authors:  M B Sharif Kazemi; K Eshraghian; G R Omrani; K Bagheri Lankarani; E Hosseini
Journal:  Angiology       Date:  2006 Jan-Feb       Impact factor: 3.619

7.  Association between the serum folate levels and tea consumption during pregnancy.

Authors:  Mie Shiraishi; Megumi Haruna; Masayo Matsuzaki; Erika Ota; Ryoko Murayama; Sachiyo Murashima
Journal:  Biosci Trends       Date:  2010-10       Impact factor: 2.400

8.  Impact of dietary folate intake on depressive symptoms in young women of reproductive age.

Authors:  Hiroko Watanabe; Sadayo Ishida; Yoshie Konno; Momoyo Matsumoto; Shinobu Nomachi; Kiyoko Masaki; Hisayo Okayama; Yasushi Nagai
Journal:  J Midwifery Womens Health       Date:  2011-09-23       Impact factor: 2.388

9.  Folate status of adult males living in a metabolic unit: possible relationships with iron nutriture.

Authors:  D B Milne; L K Johnson; J R Mahalko; H H Sandstead
Journal:  Am J Clin Nutr       Date:  1983-05       Impact factor: 7.045

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  3 in total

1.  5-Methyltetrahydrofolate Attenuates Oxidative Stress and Improves Kidney Function in Acute Kidney Injury through Activation of Nrf2 and Antioxidant Defense.

Authors:  Charith U B Wijerathne; Kathy K W Au-Yeung; Yaw L Siow; Karmin O
Journal:  Antioxidants (Basel)       Date:  2022-05-25

2.  Assessment of pyridoxine and folate intake in migraine patients.

Authors:  Omid Sadeghi; Zahra Maghsoudi; Fariborz Khorvash; Reza Ghiasvand; Gholamreza Askari
Journal:  Adv Biomed Res       Date:  2016-03-16

3.  Ischemia-Reperfusion Injury Reduces Kidney Folate Transporter Expression and Plasma Folate Levels.

Authors:  Cheng Yang; Charith U B Wijerathne; Guo-Wei Tu; Connie W H Woo; Yaw L Siow; Susara Madduma Hewage; Kathy K W Au-Yeung; Tongyu Zhu; Karmin O
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.